Pharmicell Co., Ltd. (005690.KS)
KRW 9180.0
(-2.24%)
KRW 9180.0
(-2.24%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 60.00 KRW | -56.72% |
| 2022 | 137.79 KRW | -12.6% |
| 2021 | 157.66 KRW | 80.31% |
| 2020 | 87.44 KRW | 20.57% |
| 2019 | 72.52 KRW | 133.89% |
| 2018 | -214.00 KRW | 68.12% |
| 2017 | -671.27 KRW | -5493.92% |
| 2016 | -12.00 KRW | 89.58% |
| 2015 | -115.17 KRW | 81.39% |
| 2014 | -619.00 KRW | -1.83% |
| 2013 | -607.88 KRW | -30.17% |
| 2012 | -467.00 KRW | 32.78% |
| 2011 | -694.74 KRW | -4.08% |
| 2010 | -667.50 KRW | -159.22% |
| 2009 | -257.50 KRW | 2.94% |
| 2008 | -265.30 KRW | -285.61% |
| 2007 | -68.80 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -22.74 KRW | -210.66% |
| 2024 Q2 | 47.13 KRW | 307.26% |
| 2023 Q4 | 20.55 KRW | 15.19% |
| 2023 FY | - KRW | -56.72% |
| 2023 Q1 | 18.05 KRW | 124.39% |
| 2023 Q2 | 9.59 KRW | -46.87% |
| 2023 Q3 | 17.84 KRW | 86.03% |
| 2022 Q1 | 82.24 KRW | 343.34% |
| 2022 Q2 | 37.26 KRW | -54.69% |
| 2022 Q4 | -74.00 KRW | -214.48% |
| 2022 Q3 | 64.64 KRW | 73.48% |
| 2022 FY | - KRW | -12.6% |
| 2021 Q1 | 32.00 KRW | 179.48% |
| 2021 Q3 | 60.00 KRW | 66.67% |
| 2021 Q4 | 18.55 KRW | -69.08% |
| 2021 Q2 | 36.00 KRW | 12.5% |
| 2021 FY | - KRW | 80.31% |
| 2020 FY | - KRW | 20.57% |
| 2020 Q3 | 12.00 KRW | -76.0% |
| 2020 Q2 | 50.00 KRW | 257.14% |
| 2020 Q4 | 11.45 KRW | -4.58% |
| 2020 Q1 | 14.00 KRW | -64.38% |
| 2019 Q4 | 39.30 KRW | 2065.0% |
| 2019 FY | - KRW | 133.89% |
| 2019 Q1 | 17.00 KRW | 108.88% |
| 2019 Q2 | 19.00 KRW | 11.76% |
| 2019 Q3 | -2.00 KRW | -110.53% |
| 2018 FY | - KRW | 68.12% |
| 2018 Q3 | -4.00 KRW | 42.86% |
| 2018 Q2 | -7.00 KRW | 22.22% |
| 2018 Q1 | -9.00 KRW | 98.53% |
| 2018 Q4 | -191.53 KRW | -4688.25% |
| 2017 FY | - KRW | -5493.92% |
| 2017 Q2 | -27.00 KRW | -28.57% |
| 2017 Q4 | -613.60 KRW | -6036.0% |
| 2017 Q3 | -10.00 KRW | 62.96% |
| 2017 Q1 | -21.00 KRW | -251.76% |
| 2016 Q1 | -5.00 KRW | 85.41% |
| 2016 Q3 | 12.00 KRW | 192.31% |
| 2016 FY | - KRW | 89.58% |
| 2016 Q2 | -13.00 KRW | -160.0% |
| 2016 Q4 | -5.97 KRW | -149.75% |
| 2015 Q2 | -20.00 KRW | 45.95% |
| 2015 Q4 | -34.28 KRW | -37.12% |
| 2015 FY | - KRW | 81.39% |
| 2015 Q1 | -37.00 KRW | 92.23% |
| 2015 Q3 | -25.00 KRW | -25.0% |
| 2014 Q3 | -44.00 KRW | 38.91% |
| 2014 FY | - KRW | -1.83% |
| 2014 Q4 | -475.97 KRW | -981.75% |
| 2014 Q2 | -72.03 KRW | -34.61% |
| 2014 Q1 | -53.51 KRW | 90.25% |
| 2013 Q2 | -69.00 KRW | -97.14% |
| 2013 FY | - KRW | -30.17% |
| 2013 Q4 | -548.64 KRW | -1406.29% |
| 2013 Q3 | 42.00 KRW | 160.87% |
| 2013 Q1 | -35.00 KRW | 81.81% |
| 2012 Q2 | -110.00 KRW | 0.67% |
| 2012 Q1 | -110.74 KRW | 41.22% |
| 2012 FY | - KRW | 32.78% |
| 2012 Q4 | -192.42 KRW | -131.83% |
| 2012 Q3 | -83.00 KRW | 24.55% |
| 2011 Q4 | -188.40 KRW | 4.22% |
| 2011 FY | - KRW | -4.08% |
| 2011 Q3 | -196.70 KRW | -24.84% |
| 2011 Q1 | -97.01 KRW | 65.66% |
| 2011 Q2 | -157.56 KRW | -62.42% |
| 2010 Q2 | -112.80 KRW | -41.0% |
| 2010 Q3 | -224.30 KRW | -98.85% |
| 2010 Q4 | -282.51 KRW | -25.95% |
| 2010 FY | - KRW | -159.22% |
| 2010 Q1 | -80.00 KRW | -5328.76% |
| 2009 Q1 | -69.80 KRW | -21.43% |
| 2009 Q2 | 21.00 KRW | 130.09% |
| 2009 Q3 | -233.00 KRW | -1209.52% |
| 2009 Q4 | 1.53 KRW | 100.66% |
| 2009 FY | - KRW | 2.94% |
| 2008 Q1 | -51.40 KRW | 11.61% |
| 2008 Q4 | -57.48 KRW | 33.78% |
| 2008 Q3 | -86.80 KRW | -315.31% |
| 2008 Q2 | -20.90 KRW | 59.34% |
| 2008 FY | - KRW | -285.61% |
| 2007 Q3 | -17.94 KRW | -281.21% |
| 2007 Q1 | -3.17 KRW | 0.0% |
| 2007 Q2 | 9.90 KRW | 412.3% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q4 | -58.15 KRW | -224.14% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | 44.726% |
| Green Cross Holdings Corporation | -1210.00 KRW | 104.959% |
| Green Cross Holdings Corporation | -2333.42 KRW | 102.571% |
| Green Cross Corporation | -2333.42 KRW | 102.571% |
| GeneOne Life Science, Inc. | -1000.23 KRW | 105.999% |
| Celltrion, Inc. | 3759.00 KRW | 98.404% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 99.502% |
| SK bioscience Co.,Ltd. | 291.00 KRW | 79.381% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | 114.289% |
| Prestige BioPharma Limited | -547.81 KRW | 110.953% |